Works matching IS 2160763X AND DT 2025 AND VI 14 AND IP 3

Results: 12

CPDD 2024 Reviewer List.

Published in:: Clinical Pharmacology in Drug Development, 2025, v. 14, n. 3, p. 189, doi. 10.1002/cpdd.1524
Publication type:: Article

Bioequivalence Study of Bedaquiline Fumarate Tablets in Healthy Chinese Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2025, v. 14, n. 3, p. 263, doi. 10.1002/cpdd.1515

By:

Yang, Man;
Pei, Yingzi;
Chen, Chen;
Xi, Jian;
Xia, Yue;
Zhang, Shuyu;
Liu, Huichen;
Li, Aimin

Publication type:

Article

Equivalence of Biosimilarity in Pharmacokinetic and Pharmacodynamic Properties of Recombinant Human Insulin Aspart.

Published in:

Clinical Pharmacology in Drug Development, 2025, v. 14, n. 3, p. 209, doi. 10.1002/cpdd.1510

By:

Dongre, Sneha A.;
Kulkarni, Gauri A.;
Thapa, Damodar;
Ghade, Nikhil;
Lona, Jeseena;
Prajapati, Hiren;
Mehta, Hiren;
Guttikar, Swati;
Krishnan, Archana R.;
Sonar, Sanjay M.

Publication type:

Article

Bioavailability, Metabolism, and Excretion of [<sup>14</sup>C]‐Tazemetostat in Patients With B‐Cell Lymphomas or Advanced Solid Tumors.

Published in:

Clinical Pharmacology in Drug Development, 2025, v. 14, n. 3, p. 231, doi. 10.1002/cpdd.1508

By:

Chen, Yingxue;
Teng, Renli;
Ogier, Julien

Publication type:

Article

Pharmacokinetics of Depemokimab Delivered by Safety Syringe Device or Autoinjector in Healthy Adults: A Phase 1, Single‐Dose Study.

Published in:

Clinical Pharmacology in Drug Development, 2025, v. 14, n. 3, p. 190, doi. 10.1002/cpdd.1506

By:

Schalkwijk, Stein;
Zecchin, Chiara;
Sen, Anusmita;
Choi, Sei;
Wang, Kai;
Min, Jeff;
Spears, Brian

Publication type:

Article

Bioequivalence Study of 2 Formulations of Fluticasone Nasal Spray in Healthy Chinese Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2025, v. 14, n. 3, p. 270, doi. 10.1002/cpdd.1505

By:

Chen, Gang;
Wang, Zejuan;
Liu, Xiaona;
Du, Aihua;
Li, Min;
Zhang, Yanan;
Zhang, Dan;
Wang, Xiaolin;
Li, Xueyan;
Cong, Wei;
Wang, Jin

Publication type:

Article

Phase 1 Mass Balance Study of Pizuglanstat: An Investigational Hematopoietic Prostaglandin D Synthase Inhibitor.

Published in:

Clinical Pharmacology in Drug Development, 2025, v. 14, n. 3, p. 200, doi. 10.1002/cpdd.1504

By:

Hanada, Ryuzo;
Takenaka, Toru

Publication type:

Article

Population Pharmacokinetic Modeling of Certepetide in Human Subjects With Metastatic Pancreatic Ductal Adenocarcinoma.

Published in:

Clinical Pharmacology in Drug Development, 2025, v. 14, n. 3, p. 240, doi. 10.1002/cpdd.1502

By:

Winning, Alex;
Sietsema, William K.;
Buck, Kristen K.;
Linsmeier, Abigail;
Wiczling, Pawel

Publication type:

Article

A Drug–Drug Interaction Study of Mobocertinib and Midazolam, a Cytochrome P450 3A Substrate, in Patients With Advanced Non–Small Cell Lung Cancer.

Published in:

Clinical Pharmacology in Drug Development, 2025, v. 14, n. 3, p. 252, doi. 10.1002/cpdd.1500

By:

Hanley, Michael J.;
Zhang, Steven;
Pavlakis, Nick;
Soo, Ross A.;
van der Wekken, Anthonie J.;
Ganju, Vinod;
Piña, Adela;
Dong, Qi;
Gupta, Neeraj

Publication type:

Article

Antipyretic Effect of Dexibuprofen Versus Ibuprofen in Children With Fever Caused by Upper Respiratory Tract Infection.

Published in:

Clinical Pharmacology in Drug Development, 2025, v. 14, n. 3, p. 223, doi. 10.1002/cpdd.1499

By:

Zhao, Chengsong;
Zhao, Lin;
Xie, Juanjuan;
Wang, Xinli;
Li, Changchong;
Cheng, Huanji;
Shen, Kunling

Publication type:

Article

Determination of the Bioavailability of 3 Intranasal Formulations of Azelastine Hydrochloride in Healthy Male Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2025, v. 14, n. 3, p. 217, doi. 10.1002/cpdd.1498

By:

Bousquet, Jean;
Klimek, Ludger;
Liu, Mark;
Nguyen, Duc Tung;
Ramalingam, Rajesh Kumar;
Canonica, Georgio Walter;
Berger, William E.

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2025, v. 14, n. 3, p. 185, doi. 10.1002/cpdd.1280
Publication type:: Article